1 study found for:    2139281 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
Condition: Chronic Hepatitis B
Intervention: Drug: Lamivudine/ Placebo 100mg daily

Indicates status has not been verified in more than two years